Zhejiang Jiuzhou Pharm Co Ltd Net Asset Quality Index
Zhejiang Jiuzhou Pharm Co Ltd net asset quality index. Zhejiang Jiuzhou Pharm Co Ltd (603456) has a Net Asset Quality Index of 84.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.64 Billion minus total liabilities of CN¥1.68 Billion yields net assets of CN¥8.96 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Zhejiang Jiuzhou Pharm Co Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zhejiang Jiuzhou Pharm Co Ltd (2008–2025)
Net asset quality index of Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025. This chart shows how Zhejiang Jiuzhou Pharm Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 84.2%, representing net assets of CN¥8.96 Billion against total assets of CN¥10.64 Billion CNY. Check Zhejiang Jiuzhou Pharm Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Zhejiang Jiuzhou Pharm Co Ltd Net Asset Quality Index by Year (2008–2025)
Zhejiang Jiuzhou Pharm Co Ltd net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603456 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.9% | CN¥8.79 Billion | CN¥10.60 Billion | CN¥1.81 Billion | ▲ +5.5 pp |
| 2024 | 77.4% | CN¥8.61 Billion | CN¥11.13 Billion | CN¥2.52 Billion | ▼ -1.3 pp |
| 2023 | 78.6% | CN¥8.53 Billion | CN¥10.85 Billion | CN¥2.32 Billion | ▲ +10.8 pp |
| 2022 | 67.9% | CN¥5.37 Billion | CN¥7.91 Billion | CN¥2.54 Billion | ▲ +2.9 pp |
| 2021 | 65.0% | CN¥4.58 Billion | CN¥7.04 Billion | CN¥2.46 Billion | ▲ +3.3 pp |
| 2020 | 61.7% | CN¥3.09 Billion | CN¥5.00 Billion | CN¥1.92 Billion | ▲ +0.5 pp |
| 2019 | 61.2% | CN¥2.86 Billion | CN¥4.67 Billion | CN¥1.81 Billion | ▼ -22.9 pp |
| 2018 | 84.1% | CN¥2.78 Billion | CN¥3.30 Billion | CN¥526.81 Million | ▼ -1.2 pp |
| 2017 | 85.3% | CN¥2.68 Billion | CN¥3.14 Billion | CN¥461.77 Million | ▼ -0.3 pp |
| 2016 | 85.6% | CN¥2.57 Billion | CN¥3.00 Billion | CN¥432.01 Million | ▲ +10.2 pp |
| 2015 | 75.4% | CN¥2.52 Billion | CN¥3.34 Billion | CN¥819.46 Million | ▲ +3.7 pp |
| 2014 | 71.7% | CN¥1.58 Billion | CN¥2.21 Billion | CN¥624.98 Million | ▲ +24.2 pp |
| 2013 | 47.5% | CN¥736.75 Million | CN¥1.55 Billion | CN¥814.26 Million | ▲ +3.1 pp |
| 2012 | 44.4% | CN¥597.08 Million | CN¥1.34 Billion | CN¥746.26 Million | ▲ +3.1 pp |
| 2011 | 41.4% | CN¥460.54 Million | CN¥1.11 Billion | CN¥653.04 Million | ▲ +1.2 pp |
| 2010 | 40.2% | CN¥343.94 Million | CN¥855.97 Million | CN¥512.03 Million | ▲ +1.4 pp |
| 2009 | 38.8% | CN¥245.87 Million | CN¥634.32 Million | CN¥388.45 Million | ▲ +8.9 pp |
| 2008 | 29.9% | CN¥175.41 Million | CN¥586.69 Million | CN¥411.27 Million | — |